baseedge_labs
Globex Surge - a rider on a neon motorcycle outpacing a swirling tunnel of currency symbols down a rain-slick Tokyo street at night
← strategies

Globex Surge

v1.3.3 · MNQ / US100 (CFD) ·version history

The current version. Earlier versions keep their own pages.

limited beta
net pnl
$18,758
trades
185

Hypothetical backtest · 1 MNQ contract · $0.62/side commission and 1 tick slippage per side included · not a prediction of future results

Where it stands

Globex Surge is available as a Limited Beta on TradingView: an invite-only script, $24.99 as a one-time payment, with 30 days of access (if the Beta ends sooner, for any reason, we refund the days you didn’t get, pro rata). Get access; access usually goes to your TradingView username within one business day.

It is still in forward testing on our own accounts, and the strategy may change during the Beta. The results on this page are backtests, TradingView’s own runs of the chart: hypothetical, not a record of real trading, and no promise of what the Beta will do. Full access is planned through NinjaTrader 8, with Monthly, Yearly and One-time licenses, and possibly through a TradingView Creator Space.

What changed in v1.3.3

One strategy, both sessions. Sunday and Monday used to be two separate charts. v1.3.3 runs both on one chart as Session 1 and Session 2, each with its own day, direction, entry time and trade management. That leaves one script to load and one set of alerts to wire. A Monday trade still open when Sunday’s next session begins is closed first, so the chart never holds two positions.

Out on a clock. Each session now has its own Close All time. Sunday’s trade is closed by 8:00 a.m. New York time; Monday’s by 10:30 a.m., an hour into the cash session. Earlier versions could hold a trade through the New York day.

Sunday’s settings were retuned around the live chart and tested on Micro Nasdaq futures and the US100 CFD back to January 2024, in three separate stretches rather than only as a whole (hypothetical backtests). They beat v1.2.0’s Sunday in every stretch except the earliest one on MNQ. Monday keeps v1.2.0’s live settings: the alternatives we tried lost to them in every stretch.

The same MNQ chart, one contract, the same TradingView year (12 October 2025 to 6 October 2026), both sessions:

Sunday + Monday · MNQ, 1 contracttradesnetprofit factormax drawdown
v1.2.0 rules (no Close All)186+$17,4063.11$679
v1.3.3185+$18,7583.30$626

Hypothetical backtest · 1 MNQ contract · $0.62/side commission and 1 tick slippage per side included · not a prediction of future results

Both rows are TradingView Strategy Tester runs of the v1.3.3 script. The first runs v1.2.0’s settings with the Close All times switched off, which is how v1.2.0 traded. Every one of the 13 months finished positive. Max drawdown here is measured on closed trades. Sunday’s settings were chosen on history that includes this year, so these figures are partly in-sample: they show how well the settings fit the past, not what to expect.

Thursday, on its own chart

New since the first v1.3.3 charts: a Thursday-night long, run as a second chart of the same script with only one session switched on, so it never overlaps the Sunday and Monday trades. On the TradingView year to 9 October 2026 it took 82 trades for +$7,068, profit factor 2.25, on MNQ, and 82 trades for +$7,762 (profit factor 2.40) on the US100 CFD at two units.

It is a recent effect. In the twelve months before that it roughly broke even (72 trades: +$299 on MNQ, +$348 on US100). We run it as a trade on the market as it is now, and we will retire it if its rolling year stops holding up. Tuesday, Wednesday and every short from Tuesday to Thursday showed no edge worth trading. Thursday was chosen on this same year, so its figures are in-sample.

Hypothetical backtest · 1 MNQ contract · $0.62/side commission and 1 tick slippage per side included · not a prediction of future results

Hypothetical backtest · 0.02 lots US100 (2 units, $2/pt ≈ 1 MNQ in exposure) · zero commission and 1 tick slippage per side included; spread not included · not a prediction of future results

What is measured below

The first two tabs are the Sunday + Monday chart as it runs, on Micro Nasdaq futures (MNQ) and on the US100 CFD; the other two are the Thursday chart on the same two markets. Every figure is from TradingView’s Strategy Tester on that chart. The period is the last 365 days to 6 October 2026, with the stretch since 27 June shown separately.

US100 is measured on OPO Finance’s Nasdaq-100 CFD feed (OPOFINANCE:NDQUSD) at two units, the same exposure as one MNQ contract. CFD prices and volume differ by broker, so results on another broker’s chart will differ.

The Thursday tabs show their last 365 days, to 9 October 2026. The headline on the strategies page is the MNQ chart at one contract.

Measured results

One tab per live chart. The settings stay private while the strategy is in forward testing; the results are TradingView's own.

Last 365 days

2025-10-12 to 2026-10-06 · CME_MINI:MNQ1!
net P&L
$18,758
profit factor
3.29
win rate
64.3%
trades
119 / 185
max drawdown
-$626
avg trade
$101
largest loss
-$282
months +
13 / 13

Sunday + Monday · MNQ · Last 365 days

CME_MINI:MNQ1! · 185 trades · 2025-10-12 to 2026-10-06

net pnl
$18,758
max drawdown
-$626
Equity curve
$19,022$9,412-$197
Drawdown
$0-$313-$626
2025-10-122026-10-06
View monthly data table
MonthEquityDrawdown
2025-10$91-$278
2025-11$1,677-$599
2025-12$3,855-$21
2026-01$4,873-$263
2026-02$5,862-$418
2026-03$8,527-$202
2026-04$9,840$0
2026-05$11,133$0
2026-06$12,171$0
2026-07$14,218$0
2026-08$16,280-$220
2026-09$18,751$0
2026-10$18,758-$263

Hypothetical backtest · 1 MNQ contract · $0.62/side commission and 1 tick slippage per side included · not a prediction of future results

Since 27 June 2026

2026-06-28 to 2026-10-06 · CME_MINI:MNQ1!
net P&L
$7,121
profit factor
5.06
win rate
74.5%
trades
41 / 55
max drawdown
-$312
avg trade
$129
largest loss
-$202
months +
5 / 5

Sunday + Monday · MNQ · Since 27 June 2026

CME_MINI:MNQ1! · 55 trades · 2026-06-28 to 2026-10-06

net pnl
$7,121
max drawdown
-$312
Equity curve
$7,384$3,692$0
Drawdown
$0-$156-$312
2026-06-282026-10-06
View monthly data table
MonthEquityDrawdown
2026-06$533$0
2026-07$2,581$0
2026-08$4,643-$220
2026-09$7,114$0
2026-10$7,121-$263

Hypothetical backtest · 1 MNQ contract · $0.62/side commission and 1 tick slippage per side included · not a prediction of future results

Every figure is a TradingView Strategy Tester result: the broker emulator's own trades, closed-trade equity, as configured on that chart. Both windows come from the same run; the shorter one is contained in the longer.

Get access

Access is given to your TradingView username, usually within one business day of purchase, and the script then appears under Invite-only scripts in your Indicators menu and on its TradingView page. You'll sign in or create a free account at checkout. On sale in the United States and the countries on our where we sell page. Outside the United States, checkout is run by Link, Stripe's checkout, in your currency with your country's tax added.

Limited Beta
$24.99one-time payment · access during the Beta

Access to Globex Surge on TradingView during its Beta, for one TradingView username. 30 days of access; if the Beta ends sooner, for any reason, we refund the days you didn't get, pro rata. After that it may end with at least 14 days' email notice, or sooner if TradingView ends or blocks access. Access once TradingView's new rules for invite-only scripts take effect is not guaranteed beyond what TradingView allows. No future paid version is included; moving to Monthly, Yearly or One-time credits the days you haven't used against its first payment. The Beta's terms.

Monthly
$34.99a month

A subscription for one TradingView username, renewing every month until you cancel. When you cancel, access runs to the end of the month you paid for. Payments are final. If TradingView removes the script or requires it to move to its Marketplace, we move your access there or refund the unused part. How a move works.

Yearly
$275a year

A subscription for one TradingView username, renewing every year until you cancel. When you cancel, access runs to the end of the year you paid for. Payments are final. If TradingView removes the script or requires it to move to its Marketplace, we move your access there or refund the unused part. How a move works.

One-time
$499one-time payment · perpetual license & updates (see terms)

A perpetual, non-transferable license to Globex Surge for one TradingView username, for as long as we publish it on TradingView and TradingView's rules allow your access, with at least 12 months of updates, then updates to the version you have. A major new version may be a paid upgrade. Final sale except as our terms say.

The Limited Beta pass is on sale while the Beta lasts. Monthly, Yearly and One-time are the plans for Globex Surge. NinjaTrader 8 versions are in development.

Payments are final, except as our refund policy describes (a purchase we never delivered, a billing error, or where the law requires it). The Beta pass: if the Beta ends within 30 days of your purchase we refund the days you didn't get, pro rata, and moving to a full plan credits the days you haven't used against its first payment. Any plan: if TradingView removes the script or requires it to move to its Marketplace or a Creator Space, we move your access or refund the unused part. See the refund policy, the terms and the disclosures. Nothing here is investment advice.